MagnetisMM-30

A Phase 1B, Open-Label Study of Elranatamab in Combination with Iberdomide in Participants with Relapsed Refractory Multiple Myeloma

Near Add Your Location

Sorting 26 by

Memorial Sloan Kettering Cancer Center
New York, NY
  • Accepting patients
  • Show Principal Investigator
Memorial Sloan Kettering Commack
Commack, NY
  • Accepting patients
  • Show Principal Investigator
Sylvester Comprehensive Cancer Center
University of Miami
Coral Gables, FL
  • Accepting patients
Dartmouth-Hitchcock Medical Center
Norris Cotton Cancer Center
Lebanon, NH
  • Accepting patients
Simon Cancer Center
Indiana University
Indianapolis, IN
  • Accepting patients
Fred Hutchinson Cancer Research Center
University of Washington Cancer Consortium / SCCA
Seattle, WA
  • Not yet accepting
Methodist Hospital
Nebraska Methodist Health System
Omaha, NE
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.